V2V Wins 2025 International Torch Award

Vision2Voice Healthcare Communications is honored to be named one of five winners of the 2025 BBB International Torch Awards for Ethics! V2V has previously been awarded in the USA at the regional level on five previous occasions, but this recognition marks our first on the international stage. For over a decade, the BBB’s Torch Award for Ethics has been the only major award V2V has submitted for because it’s the only award that affirms our commitment to our core values, which have shaped every decision and client relationship.

“We’ve long believed The Torch Award is the most significant recognition Vision2Voice can achieve as an organization. Since our founding, our respect-centered core values have been at the forefront of each complex decision we’ve made as a company,” said Daniel Rehal, President and Founder of V2V. “This Torch Award is validation that our people have created something special by making big commitments, keeping them, and conducting our business the right way.”

Since 1996, these awards have celebrated North American for-profit businesses that uphold ethical practices and foster trust in the marketplace. Thank you to the International Association of Better Business Bureaus (IABBB) and to our employees, clients, stakeholders, and supporters who made this achievement possible!

Recent Posts

Man in suit holding back dominos

Will Your Launch Strategy Succeed or Fail?

The Challenge: A Faster, More Complex Launch Environment In today’s pharmaceutical market, strong science is the foundation, but it doesn’t always guarantee a successful launch....

Read More
Story 2

Industry Insights – June 2026

From evolving China deal dynamics and prolonged job searches to the growing push for AI-driven drug repurposing, explore how shifts in BioPharma are redefining innovation,...

Read More
FDA Commissioner Marty Makary, M.D.

Industry Insights – May 2026

Biosimilars are gaining U.S. momentum even as patent thickets keep triggering legal fights, small biotechs are feeling the pressure of the FDA’s faster-moving approval environment,...

Read More